Overview

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

Status:
RECRUITING
Trial end date:
2025-10-16
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Phase:
PHASE1
Details
Lead Sponsor:
Andrew T. Goldstein, MD
Collaborator:
Stratpharma AG